Search results (202)
« Back to NewsIt's beginning to look a lot like Gutmas!
28 November 2025
Congratulations to Vy Wien Lai, whose image was chosen for 1st place in the MRC/MRF 2025 Festive Science Image Competition.
Study reveals how drug resistance develops early in targeted AML therapy
17 November 2025
A new study led by researchers at the MRC Molecular Haematology Unit has shown that resistance to a targeted treatment for acute myeloid leukaemia (AML) can develop much earlier than expected.
Iron supplement absorption preserved in children with HIV and boosted by prebiotics
13 November 2025
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Oxford scientists capture genome’s structure in unprecedented detail
5 November 2025
RDM scientists have achieved the most detailed view yet of how DNA folds and functions inside living cells, revealing the physical structures that control when and how genes are switched on.
Abdullah Khan receives Wellcome Career Development Award
4 November 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
Unravelling T-Cell Recognition: Insights from Immunology and AI
13 October 2025
From 29 September to 1 October 2025, researchers from across the world gathered in Oxford for a unique conference and hackathon exploring how advances in artificial intelligence can deepen understanding of T-cell biology.
Congratulations to RDM’s new Professors
1 October 2025
Three RDM researchers have been awarded the title of Full Professor in the University’s 2025 Recognition of Distinction exercise.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
‘Targeted Therapies’ at Big Bang Fair 2025
20 August 2025
Earlier this year, a group of researchers from the MRC Weatherall Institute of Molecular Medicine attended the Big Bang Fair in Birmingham, showcasing medical research through a series of hands-on activities.
Platelets shown to store DNA in study that could transform cancer screening
15 August 2025
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
Wellcome Discovery Award for Claus Nerlov
31 July 2025
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.
New study links cancer stage to strength of antitumoral immune response in HR+ breast cancer
29 July 2025
The latest study from researchers in the MRC Translational Immune Discovery Unit in the MRC Weatherall Institute of Molecular Medicine has been published in Cell Reports Medicine.
Making it Personal – Engaging the public through theatre
14 July 2025
Innovative public engagement project explores the intersection of cutting-edge science and the raw honesty of the stage.
Thelior Bio: rethinking gut health from the inside out
10 July 2025
A new spinout company, formed from research conducted at the MRC Translational Immune Discovery Unit, aims to develop a new class of therapies for patients with inflammatory bowel disease.
New tool allows researchers to track how mutations arise in tissues
3 July 2025
Researchers at the MRC Weatherall Institute of Molecular Medicine and the German Cancer Research Center (DKFZ) have developed a new method to analyse how our tissues evolve as we age.
Celebrating science, collaboration and excellence at WIMM Day 2025
1 July 2025
The MRC Weatherall Institute of Molecular Medicine (WIMM) community gathered for its flagship annual event, WIMM Day, on Tuesday 24 June. Held at the Saïd Business School, the day showcased the breadth and impact of research across the institute and celebrated achievements in mentorship, public engagement and more.
Sten Eirik W. Jacobsen retires from the Bass Professorship
26 June 2025
On 30 June Professor Sten Eirik W. Jacobsen is retiring after 19 years as the Bass Professor of Developmental and Stem Cell Biology at the University of Oxford. His work has unravelled novel insights into normal and malignant haematopoietic stem and progenitor cell biology.
RDM announces a further three Principal Investigators for 2025
26 June 2025
We are delighted to announce the designation of three new Principal Investigators (PIs).
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
RDM researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.